BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25916225)

  • 1. Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.
    Ford AC; Moayyedi P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Reinisch W
    Am J Gastroenterol; 2015 May; 110(5):716-24. PubMed ID: 25916225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia.
    Subasinghe D; Nawarathna NM; Samarasekera DN
    J Gastrointest Surg; 2011 Sep; 15(9):1562-7. PubMed ID: 21710330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort.
    Perler BK; Ungaro R; Baird G; Mallette M; Bright R; Shah S; Shapiro J; Sands BE
    BMC Gastroenterol; 2019 Apr; 19(1):47. PubMed ID: 30940072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
    Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
    Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study.
    Melmed GY; Elashoff R; Chen GC; Nastaskin I; Papadakis KA; Vasiliauskas EA; Liu W; Landers C; Ippoliti AF; Targan SR
    Clin Gastroenterol Hepatol; 2007 May; 5(5):602-8; quiz 525. PubMed ID: 17478347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.
    Matsui T; Yao T; Sakurai T; Yao K; Hirai F; Matake H; Tsuda S; Wada Y; Iwashita A; Kamachi S
    J Gastroenterol; 2003; 38(7):647-55. PubMed ID: 12898357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease.
    Castellaneta SP; Afzal NA; Greenberg M; Deere H; Davies S; Murch SH; Walker-Smith JA; Thomson M; Srivistrava A
    J Pediatr Gastroenterol Nutr; 2004 Sep; 39(3):257-61. PubMed ID: 15319625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.
    Sood R; Camilleri M; Gracie DJ; Gold MJ; To N; Law GR; Ford AC
    Am J Gastroenterol; 2016 Oct; 111(10):1446-1454. PubMed ID: 27481310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology].
    Schunk K; Reiter S; Kern A; Orth T; Wanitschke R
    Rofo; 2001 Aug; 173(8):731-8. PubMed ID: 11570244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of CD30+ lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease.
    Flores C; Francesconi CF; Meurer L
    J Crohns Colitis; 2015 Sep; 9(9):763-8. PubMed ID: 26048916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic problems of histological remission in patients with inflammatory bowel disease].
    Tertychnyi AS; Akhrieva KM; Maev IV; Zayratyants OV; Selivanova LS
    Arkh Patol; 2017; 79(3):3-9. PubMed ID: 28631710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
    Joo M; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
    Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
    Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.